10d
Investor's Business Daily on MSNThis Drug Stock Sits On A Strong Earnings Foundation As It Tests New EntryThis pharma stock has made strong gains over the past 12 months thanks to its strong earnings. Now it is testing a fresh buy ...
Laura Montgomery said Catalyst is making progress as a “one-stop shop” for substance use disorder and mental health ...
Researchers at Leipzig University have developed a new process for reversing the polarity of chemical compounds, also known as umpolung, for the precise synthesis of pharmaceuticals. This innovative ...
Hetero and Lupin); subsequently in 10/2023 a fourth generic drug manufacturer (Inventia) joined the fray. Catalyst settled with Inventia in 07/2024. The settlement provided Inventia's ...
By employing a particularly effective and precisely tailored catalyst, the researchers were ... including the antiepileptic drug pregabalin. Chirality, or the asymmetric arrangement of atoms ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results